Biotech · Private company
Vical
Track this companyFree. Adds Vical to your Dealase workspace and tells you when its record changes.
Clinical trials80 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- Investigational Agent: VL-2397Phase 2 · Invasive AspergillosisClinicalTrials.gov · fetched Nov 12, 2026
- PBSPhase 2 · Genital Herpes Simplex Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- Standard treatment: Voriconazole, Isavuconazole, or Liposomal amphotericin BPhase 2 · Invasive AspergillosisClinicalTrials.gov · fetched Nov 12, 2026
- VCL-HB01Phase 2 · Herpes GenitalisClinicalTrials.gov · fetched Nov 12, 2026
- VCL-HB01Phase 2 · Genital Herpes Simplex Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- VCL-HM01Phase 2 · Genital Herpes Simplex Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- PBSPhase 1 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- VCL-IM01 (encoding IL-2) with ElectroporationPhase 1 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- VCL-IPM1Phase 1 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- VCL-IPT1Phase 1 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in AdultsPHASE2 · TERMINATED · started Feb 20, 2018ClinicalTrials.gov NCT03327727 · fetched Nov 12, 2026
- Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA VaccinePHASE2 · COMPLETED · started Sep 1, 2016ClinicalTrials.gov NCT02837575 · fetched Nov 12, 2026
- An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis PatientsPHASE1 · COMPLETED · started Dec 30, 2013ClinicalTrials.gov NCT02103426 · fetched Nov 12, 2026
- Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in AdultsPHASE1_PHASE2 · COMPLETED · started Dec 1, 2013ClinicalTrials.gov NCT02030301 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive DonorPHASE2 · COMPLETED · started Nov 20, 2013ClinicalTrials.gov NCT01974206 · fetched Nov 12, 2026
- Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)PHASE1 · COMPLETED · started Aug 1, 2007ClinicalTrials.gov NCT00694213 · fetched Nov 12, 2026
- Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)PHASE2 · COMPLETED · started Jan 31, 2006ClinicalTrials.gov NCT00285259 · fetched Nov 12, 2026
- A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic MelanomaPHASE1 · COMPLETED · started Jul 1, 2005ClinicalTrials.gov NCT00223899 · fetched Nov 12, 2026